NanoMedical Systems, Inc.

About:

NanoMedical Systems is developing a personalized molecular drug-delivery system that improves therapeutic outcomes.

Website: http://nanomedsys.com

Description:

NanoMedical Systems develops novel drug-delivery devices based on its proprietary nStrada™ nanofluidics platform for sustained release of chronic therapies. These devices can be loaded with a variety of drugs including small molecules, peptides, and proteins for subcutaneous implantation. The nStrada™ devices rely on diffusion (passive or controlled) to achieve steady-state drug concentrations within a few days and then maintain constant release for the duration of the implant. This performance represents a significant improvement over polymer-based implants and depots which suffer from an initial burst release and multiple weeks to achieve steady-state concentrations.

Total Funding Amount:

$10.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Austin, Texas, United States

Founded Date:

2006-01-01

Contact Email:

INFO(AT)NanoMedSys.com

Founders:

David D. Saathoff, Mauro Ferrari, Randy Goodall

Number of Employees:

11-50

Last Funding Date:

2018-08-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai